Stephen B. Edge MD, FACS, FASCO

Stephen B. Edge
MD, FACS, FASCO

Professor

Department of Surgery

Jacobs School of Medicine & Biomedical Sciences

Specialty/Research Focus

Oncology; Surgery

Contact Information

Roswell Park Cancer Institute
Elm & Carlton Streets
Department of Surgery
Buffalo, New York 14263
edge@buffalo.edu

View map

Overview Publications Activities Latest News

Professional Summary:

Research and Professional Goals:
1. Clilnical research program: Our work at Roswell Park Cancer Institute focuses on translational research in breast cancer diagnosis and treatment, including collaborations with other clinicians and scientists in biological markers of cancer and cancer progression.
2. Health Services Research: Using a variety of data sources, we are working on methods to define and improve the quality of cancer care. The models used for this work include administrative claims data from regional payers, and multi institutional databases through national consortiums.
3. Clinical activities: We maintain a high volume, multidisciplinary program in breast cancer diagnosis and treatment at Roswell Park Cancer Institute. Teaching, clinical trials and translational research are integrated into this program at all levels.

Education and Training:

Residency, University Hospitals of Cleveland, Case Western Reserve Univ. (1986)
Fellowship, National Cancer Institute, Surgery Branch, Bethesda (1984)
Internship, University Hospitals of Cleveland, Case Western Reserve University Surgery Program, Cleveland (1980)
MD, Case Western Reserve University, Cleveland (1979)
BA, Tufts University, Medford (1975)
Residency, University Hospitals of Cleveland, Case Western Reserve University Surgery Program, Cleveland

Employment:

Professor Emeritus, Oncology, Roswell Park Comprehensive Cancer Center (2024-present)
Professor, Surgery, University at Buffalo (2004-present)
Professor, Surgical Oncology, Roswell Park Comprehensive Cancer Center (2016–2024)
Clinical Professor, Surgery, Vanderbilt University (2014–2015)
Professor, Oncology, Roswell Park Comprehensive Cancer Center

Journal Articles:

Gonzalez Bosquet J, Polio A, George E, Tarhini AA, Cosgrove CM, Huang MS, Corr B, Leiser AL, Salhia B, Darcy K, Tarney CM, Dood RL, Dockery LE, Edge SB, Cavnar MJ, Landrum L, Rounbehler RJ, Churchman M, Wagner VM. (2025) Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer Recurrence. JCO precision oncology (May), 9: e2400859.
Winchester DJ, Singh L, Edge SB, Allison KH, Barlow WE, Bossuyt V, Chavez-MacGregor M, Conant EF, Connolly JL, De Los Santos JF, Hayes DF, Hylton NM, Mittendorf EA, Plichta JK, Provenzano E, Salerno KE, Sharma P, Symmans WF, Weaver D, Hortobagyi GN, , . (2025) Novel Postneoadjuvant Prognostic Breast Cancer Staging System. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (Apr)JCO2401739.
Mukhtar RA, Gottipati S, Yau C, López-Tarruella S, Earl H, Hayward L, Hiller L, Osdoit M, van der Noordaa M, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, Boughey JC, Goetz MP, Hoskin T, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Provenzano E, Sammut SJ, Thomas JS, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, J van 't Veer L, Cameron D, Esserman LJ, Fraser Symmans W. (2025) A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer. NPJ breast cancer (Feb), 11(1): 14. doi:10.1038/s41523-025-00720-3
Lakritz S, Nicklawsky A, Alami V, Kohli M, Moskaluk C, Riedlinger G, Salhia B, Singer EA, Naqash AR, Nepple K, Edge S, Myint Z, Kolesar J, Adra N, Flaig T, Graham LS. (2025) Activity of Platinum Chemotherapy in Men With Prostate Cancer With and Without DNA Damage Repair Mutations. Clinical genitourinary cancer (Feb), 23(1): 102293.
Gandhi S, Slomba RT, Janes C, Fitzpatrick V, Miller J, Attwood K, Ioannou G, Ozbey S, De Souza I, Roudko V, Kumar P, Kalathil S, Kokolus KM, Wang J, Cortes Gomez E, Takabe K, Edge S, Young J, Cappuccino H, Opyrchal M, O'Connor T, Levine EG, Gnjatic S, Kalinski P. (2024) Systemic chemokine-modulatory regimen combined with neoadjuvant chemotherapy in patients with triple-negative breast cancer. Journal for immunotherapy of cancer (Nov), 12(11). doi:10.1136/jitc-2024-010058
Krecko LK, Neuman HB, Greenberg CC, Wilke LG, Hanlon BM, Edge SB, Ruddy KJ, Partridge AH, Le-Rademacher J, Yang DY, Havlena J, R Schumacher J. (2024) Validation of the AJCC 8th Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01). Annals of surgical oncology (Sep), 31(9): 5880-5887. doi:10.1245/s10434-024-15477-5
Gupta A, Roy AM, Gupta K, Attwood K, Gandhi A, Edge S, Takabe K, Repasky E, Yao S, Gandhi S. (2024) Impact of environmental temperature on the survival outcomes of breast cancer: A SEER-based study. Breast cancer research and treatment (Sep), 207(2): 383-392. doi:10.1007/s10549-024-07369-9
Kohlmann W, Nix DA, Pauley K, Greenberg S, Atkinson A, Boucher KM, Kolesar J, Singer EA, Edge SB, Churchman ML, Graham L, Salhia B, Sanchez A, Zakharia Y, Nepple KG, Schneider BP, Byrne L, Jain RK, Chahoud J, Feng BJ, Gupta S. (2024) Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor Genomics. JCO precision oncology (Jun), 8: e2300697. doi:10.1200/PO.23.00697
Oturkar CC, Rosario SR, Hutson AD, Groman A, Edge SB, Morrison CD, Swetzig WM, Wang J, Park JH, Kaipparettu BA, Singh PK, Kumar S, Cappuccino HH, Ranjan M, Adjei A, Ghasemi M, Goey AKL, Kulkarni S, Das GM. (2024) ESR1 and p53 interactome alteration defines mechanisms of tamoxifen response in luminal breast cancer. iScience (Jun), 27(6): 109995. doi:10.1016/j.isci.2024.109995
Edge SB. (2024) Invited Commentary: Path to Omission of Axillary Surgery after Neoadjuvant Therapy for Breast Cancer. Journal of the American College of Surgeons (Mar), 238(3): 311-312.
Bernicker E, Averbuch SD, Edge S, Kamboj J, Khuri FR, Pierce JY, Schiller J, Sirohi B, Thomas A, Moushey A, Phillips J, Hendricks C. (2024) Climate Change and Cancer Care: A Policy Statement From ASCO. JCO oncology practice (Feb), 20(2): 178-186.
Allen CJ, Snyder RA, Horn DM, Hudson MF, Barber A, Smieliauskas F, Spears PA, Edge S, Greenup RA. (2023) Defining Priorities in Value-Based Cancer Care: Insights From the Alliance for Clinical Trials in Oncology National Cooperative Group Survey. JCO oncology practice (Oct), 19(10): 932-938. doi:10.1200/OP.23.00159
Loggers ET, Case AA, Chwistek M, Dale W, Delgado Guay MO, Edge SB, Grossman SR, Gustin J, Nelson J, Rajasekhara S, Reddy A, Tulsky JA, Zachariah F, Landrum KM. (2023) ADCC's Improving Goal Concordant Care Initiative: Implementing Primary Palliative Care Principles. Journal of pain and symptom management (Aug), 66(2): e283-e297.
Sabih Q, Cappuccino H, Edge S, Takabe K, Young J. (2023) Burnout in the female surgical trainee; is it time to consider a more global approach to tackle this issue?. Surgery in practice and science (Jun), 13: 100162. doi:10.1016/j.sipas.2023.100162
Rosario SR, Dong B, Zhang Y, Hsiao HH, Isenhart E, Wang J, Siegel EM, Monjazeb AM, Owen DH, Dey P, Tabung FK, Spakowicz DJ, Murphy WJ, Edge S, Yendamuri S, Ibrahimi S, Kolesar JM, McDonald PH, Vadehra D, Churchman M, Liu S, Kalinski P, Mukherjee S. (2023) Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers. International journal of molecular sciences (Jun), 24(13). doi:10.3390/ijms241310847
Plichta JK, Thomas SM, Hayes DF, Chavez-MacGregor M, Allison K, de Los Santos J, Fowler AM, Giuliano AE, Sharma P, Smith BD, van Eycken E, Edge SB, Hortobagyi GN. (2023) Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (May), 41(14): 2546-2560. doi:10.1200/JCO.22.02222
Neuman HB, Schumacher JR, Edge SB, Ruddy KJ, Partridge AH, Yu M, Vanness DJ, Hanlon BM, Le-Rademacher JG, Yang DY, Havlena J, Strand CA, Greenberg CC. (2023) The influence of anatomic stage and receptor status on first recurrence for breast cancer within 5 years (AFT-01). Cancer (May), 129(9): 1351-1360. doi:10.1002/cncr.34656
Schumacher JR, Wiener AA, Greenberg CC, Hanlon B, Edge SB, Ruddy KJ, Partridge AH, Le-Rademacher JG, Yu M, Vanness DJ, Yang DY, Havlena J, Strand C, Neuman HB. (2023) Local/Regional Recurrence Rates After Breast-Conserving Therapy in Patients Enrolled in Legacy Trials of the Alliance for Clinical Trials in Oncology (AFT-01). Annals of surgery (May), 277(5): 841-845. doi:10.1097/SLA.0000000000005776
Gupta A, Gupta K, Roy AM, Attwood K, Gandhi A, Edge S, Takabe K, Repasky E, Yao S, Gandhi S. (2023) Impact of Environmental Temperature on the Pathological Complete Response and Survival Outcomes of Breast Cancer: A NCDB and SEER study. Research square (Mar). doi:10.21203/rs.3.rs-2718368/v1
Hoskins EL, Samorodnitsky E, Wing MR, Reeser JW, Hopkins JF, Murugesan K, Kuang Z, Vella R, Stein L, Risch Z, Yu L, Adebola S, Paruchuri A, Carpten J, Chahoud J, Edge S, Kolesar J, McCarter M, Nepple KG, Reilley M, Scaife C, Tripathi A, Single N, Huang RSP, Albacker LA, Roychowdhury S. (2023) Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations. JCO precision oncology (Jan), 7: e2200300. doi:10.1200/PO.22.00300
Schumacher JR, Neuman HB, Yu M, Vanness DJ, Si Y, Burnside ES, Ruddy KJ, Partridge AH, Schrag D, Edge SB, Zhang Y, Jacobs EA, Havlena J, Francescatti AB, Winchester DP, McKellar DP, Spears PA, Kozower BD, Chang GJ, Greenberg CC, . (2022) Surveillance Imaging vs Symptomatic Recurrence Detection and Survival in Stage II-III Breast Cancer (AFT-01). Journal of the National Cancer Institute (Oct), 114(10): 1371-1379. doi:10.1093/jnci/djac131
Angarita FA, Brumer R, Castelo M, Esnaola NF, Edge SB, Takabe K. (2022) De-Escalating the Management of In Situ and Invasive Breast Cancer. Cancers (Sep), 14(19). doi:10.3390/cancers14194545
Knudsen ES, Schultz E, Hamilton D, Attwood K, Edge S, O'Connor T, Levine E, Witkiewicz AK. (2022) Real-World Experience with CDK4/6 Inhibitors for Metastatic HR+/HER2- Breast Cancer at a Single Cancer Center. The oncologist (Aug), 27(8): 646-654. doi:10.1093/oncolo/oyac089
Wang Z, Tu C, Pratt R, Khoury T, Qu J, Fahey JW, McCann SE, Zhang Y, Wu Y, Hutson AD, Ambrosone CB, Edge SB, Cappuccino HH, Takabe K, Young JS, Tang L. (2022) A Presurgical-Window Intervention Trial of Isothiocyanate-Rich Broccoli Sprout Extract in Patients with Breast Cancer. Molecular nutrition & food research (Jun), 66(12): e2101094. doi:10.1002/mnfr.202101094
Angarita FA, Oshi M, Yamada A, Yan L, Matsuyama R, Edge SB, Endo I, Takabe K. (2022) Low RUFY3 expression level is associated with lymph node metastasis in older women with invasive breast cancer. Breast cancer research and treatment (Feb), 192(1): 19-32. doi:10.1007/s10549-021-06482-3
Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, López-Tarruella S, , Boughey JC, Goetz MP, Hoskin T, Gould R, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Earl H, Hayward L, Hiller L, Provenzano E, Sammut SJ, Thomas JS, Cameron D, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, van 't Veer LJ, Esserman LJ, Symmans WF. (2022) Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. The Lancet. Oncology (Jan), 23(1): 149-160. doi:10.1016/S1470-2045(21)00589-1
Bleicher RJ, Moran MS, Ruth K, Edge SB, Dietz JM, Wilke LG, Stearns V, Kurtzman SH, Klein J, Yao KA. (2022) The Impact of Radiotherapy Delay in Breast Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures. Annals of surgical oncology (Jan), 29(1): 469-481. doi:10.1245/s10434-021-10512-1
McKinney M, Bell R, Samborski C, Attwood K, Dean G, Eakle K, Yu W, Edge S. (2021) Clinical Trial Participation: A Pilot Study of Patient-Identified Barriers. Clinical journal of oncology nursing (Dec), 25(6): 647-654. doi:10.1188/21.CJON.647-654
Murthy V, Young J, Tokumaru Y, Quinn M, Edge SB, Takabe K. (2021) Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer. Cancers (Aug), 13(16). doi:10.3390/cancers13164167
Edge SD, Renard I, Pyne E, Li C, Moody H, Roy R, Beavis AW, Archibald SJ, Cawthorne CJ, Maher SG, Pires IM. (2021) PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma. The British journal of radiology (Mar), 94(1119): 20201191. doi:10.1259/bjr.20201191
Kagedan DJ, Edge SB, Takabe K. (2021) Behind the clock: elucidating factors contributing to longer clinic appointment duration and patient wait time. BMC health services research (Jan), 21(1): 87. doi:10.1186/s12913-021-06079-y
Yang DD, Buscariollo DL, Cronin AM, Weng S, Hughes ME, Bleicher RJ, Cohen AL, Javid SH, Edge SB, Moy B, Niland JC, Wolff AC, Hassett MJ, Punglia RS. (2020) Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer. Radiat Oncol (Aug), 15(1): 198-198.
D'Amico TA, Bandini LAM, Balch A, Benson AB, Edge SB, Fitzgerald CL, Green RJ, Koh WJ, Kolodziej M, Kumar S, Meropol NJ, Mohler JL, Pfister D, Walters RS, Carlson RW. (2020) Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and Concepts. J Natl Compr Canc Netw (Jan), 18(3): 250-259.
Nesline MK, DePietro P, Dy GK, Early A, Papanicolau-Sengos A, Conroy JM, Lenzo FL, Glenn ST, Chen H, Grand'Maison A, Boland P, Ernstoff MS, Puzanov I, Edge S, Akers S, Opyrchal M, Chatta G, Odunsi K, Frederick P, Lele S, Gardner M, Morrison C. (2019) Oncologist uptake of comprehensive genomic profile guided targeted therapy. Oncotarget (Jul), 10(45): 4616-4629. doi:10.18632/oncotarget.27047
Fatunmbi M, Saunders A, Chugani B, Echeazu I, Masika M, Edge S, Nwogu C. (2019) Cancer Registration in Resource-limited Environments-Experience in Lagos, Nigeria. The Journal of surgical research (Mar), 235: 167-170. doi:10.1016/j.jss.2018.09.021
Dy GK, Nesline MK, Papanicolau-Sengos A, DePietro P, LeVea CM, Early A, Chen H, Grand'Maison A, Boland P, Ernstoff MS, Edge S, Akers S, Opyrchal M, Chatta G, Odunsi K, Pabla S, Conroy JM, Glenn ST, DeFedericis HT, Burgher B, Andreas J, Giamo V, Qin M, Wang Y, Kanehira K, Lenzo FL, Frederick P, Lele S, Galluzzi L, Kuvshinoff B, Morrison C. (2019) Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing. BMC medical informatics and decision making (Jan), 19(1): 14. doi:10.1186/s12911-019-0743-x
Edge SB, Hortobagyi GN, Giuliano AE. (2019) New and important changes in breast cancer TNM: incorporation of biologic factors into staging. Expert Rev Anticancer Ther (Jan), 19(4): 309-318.
Kawaguchi T, Yan L, Qi Q, Peng X, Edge SB, Young J, Yao S, Liu S, Otsuji E, Takabe K. (2018) Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer. Ann Surg Oncol (Dec), 25(13): 4037-4046.
Dhakal A, Matthews CM, Levine EG, Salerno KE, Zhang F, Takabe K, Early AP, Edge SB, O'Connor T, Khoury T, Young JS, Opyrchal M. (2018) Efficacy of Palbociclib Combinations in Hormone Receptor-Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment. Clin Breast Cancer (Dec), 18(6): 1401-1405.
Schumacher JR, Neuman HB, Chang GJ, Kozower BD, Edge SB, Yu M, Vanness DJ, Si Y, Jacobs EA, Francescatti AB, Spears PA, Havlena J, Adesoye T, McKellar D, Winchester D, Burnside ES, Greenberg CC. (2018) A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01). Ann Surg Oncol (Sep), 25(9): 2587-2595.
Adesoye T, Schumacher JR, Neuman HB, Edge S, McKellar D, Winchester DP, Francescatti AB, Greenberg CC, . (2018) Use of Breast Imaging After Treatment for Locoregional Breast Cancer (AFT-01). Annals of surgical oncology (Jun), 25(6): 1502-1511. doi:10.1245/s10434-018-6359-z
Hortobagyi GN, Edge SB, Giuliano A. (2018) New and Important Changes in the TNM Staging System for Breast Cancer. Am Soc Clin Oncol Educ Book (May), 38: 457-467.
Hassett MJ, Jiang W, Hughes ME, Edge S, Javid SH, Niland JC, Theriault R, Wong YN, Schrag D, Punglia RS. (2018) Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ. Journal of the National Comprehensive Cancer Network : JNCCN (Apr), 16(4): 387-394.
Punglia RS, Jiang W, Lipsitz SR, Hughes ME, Schnitt SJ, Hassett MJ, Nekhlyudov L, Achacoso N, Edge S, Javid SH, Niland JC, Theriault RL, Wong YN, Habel LA. (2018) Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast cancer research and treatment (Feb), 167(3): 751-759.
Daly B, Zon RT, Page RD, Edge SB, Lyman GH, Green SR, Wollins DS, Bosserman LD. (2018) Oncology Clinical Pathways: Charting the Landscape of Pathway Providers. J Oncol Pract (Jan), 14(3): 194-200.
Neuman HB, Schumacher JR, Francescatti AB, Adesoye T, Edge SB, Vanness DJ, Yu M, McKellar D, Winchester DP, Greenberg CC. (2018) Risk of Synchronous Distant Recurrence at Time of Locoregional Recurrence in Patients With Stage II and III Breast Cancer (AFT-01). J Clin Oncol (Jan), 36(10): 975-980.
Cooley ME, Poghosyan H, Sprunck-Harrild K, Winickoff JP, Edge SB, Emmons KM. (2018) Tobacco treatment implementation within 28 commission on cancer accredited programs in the Northeast region of the USA: A pilot study. Transl Behav Med (Jan), 8(5): 706-713.
Manahan MA, Wooden WA, Becker SM, Cacioppo JR, Edge SB, Grandinetti AC, Gray DD, Holley SO, Karp NS, Kocak E, Rao R, Rosson GD, Schwartz JS, Sitzman TJ, Soltanian HT, TerKonda SP, Wallace AM. (2017) Evidence-Based Performance Measures: Quality Metrics for the Care of Patients Undergoing Breast Reconstruction. Plast Reconstr Surg (Dec), 140(6): 775-781.
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. (2017) The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin (Mar), 67(2): 93-99.
Neuss M, Rocque G, Zuckerman D, Chiang A, Katta S, Wollins D, Kamin D, Edge S. (2017) Establishing a Core Set of Performance Measures to Improve Value in Cancer Care: ASCO Consensus Conference Recommendation Report. Journal of oncology practice (Feb), 13(2): 135-140.
Al-Azhri J, Zhang Y, Bshara W, Zirpoli G, McCann SE, Khoury T, Morrison CD, Edge SB, Ambrosone CB, Yao S. (2017) Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis. Clin Cancer Res (Jan), 23(1): 97-103.
Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, Hudis CA, Hwang ES, Kirshner JJ, Morrow M, Salerno KE, Sledge GW, Solin LJ, Spears PA, Whelan TJ, Somerfield MR, Edge SB. (2017) Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Ann Surg Oncol (Jan), 24(1): 38-51.
Zon RT, Edge SB, Page RD, Frame JN, Lyman GH, Omel JL, Wollins DS, Green SR, Bosserman LD. (2017) American Society of Clinical Oncology Criteria for High-Quality Clinical Pathways in Oncology. J Oncol Pract (Jan), 13(3): 207-210.
Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ, Weaver DL, Winchester DJ, Hortobagyi GN. (2017) Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin (Jan), 67(4): 290-303.
Recht A, Somerfield MR, Edge SB. (2016) Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update Summary. Journal of oncology practice (Dec), 12(12): 1258-1261.
Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, Hudis CA, Hwang ES, Kirshner JJ, Morrow M, Salerno KE, Sledge GW, Solin LJ, Spears PA, Whelan TJ, Somerfield MR, Edge SB. (2016) Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (Dec), 34(36): 4431-4442.
Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, Hudis CA, Hwang ES, Kirshner JJ, Morrow M, Salerno KE, Sledge GW, Solin LJ, Spears PA, Whelan TJ, Somerfield MR, Edge SB. (2016) Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Pract Radiat Oncol (Nov), 6(6): 219-234.
Neuman HB, Schumacher JR, Francescatti AB, Adesoye T, Edge SB, Burnside ES, Vanness DJ, Yu M, Si Y, McKellar D, Winchester DP, Greenberg CC. (2016) Utility of Clinical Breast Examinations in Detecting Local-Regional Breast Events After Breast-Conservation in Women with a Personal History of High-Risk Breast Cancer. Ann Surg Oncol (Oct), 23(10): 3385-3391.
Halasz LM, Uno H, Hughes M, D'Amico T, Dexter EU, Edge SB, Hayman JA, Niland JC, Otterson GA, Pisters KM, Theriault R, Weeks JC, Punglia RS. (2016) Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer. Cancer (Jul), 122(13): 2091-2100.
Hill-Kayser CE, Jacobs LA, Gabriel P, Palmer SC, Hampshire MK, Vachani C, Edge SB, Metz JM. (2016) Feasibility Study of an Electronic Interface Between Internet-Based Survivorship Care Plans and Electronic Medical Records. J Oncol Pract (Apr), 12(4): 380-387.
Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA. (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol (Feb), 34(6): 611-635.
Vaz-Luis I, Hughes ME, Cronin A, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU. (2016) Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers. Breast Cancer Res Treat (Feb), 155(3): 569-578.
Partridge AH, Hughes ME, Warner ET, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM. (2016) Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival. J Clin Oncol (Jan), 34(27): 3308-3314.
Callahan CL, Wang Y, Marian C, Weng DY, Eng KH, Tao MH, Ambrosone CB, Nie J, Trevisan M, Smiraglia D, Edge SB, Shields PG, Freudenheim JL. (2016) DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study. Epigenetics (Jan), 11(9): 643-652.
Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA. (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA: a cancer journal for clinicians (Jan), 66(1): 43-73.
Tao MH, Dai Q, Millen AE, Nie J, Edge SB, Trevisan M, Shields PG, Freudenheim JL. (2015) Associations of intakes of magnesium and calcium and survival among women with breast cancer: results from Western New York Exposures and Breast Cancer (WEB) Study. Am J Cancer Res (Dec), 6(1): 105-113.
Tseng YD, Uno H, Hughes ME, Niland JC, Wong YN, Theriault R, Blitzblau RC, Moy B, Breslin T, Edge SB, Hassett MJ, Punglia RS. (2015) Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database. Int J Radiat Oncol Biol Phys (Nov), 93(3): 622-630.
Ochs-Balcom HM, Marian C, Nie J, Brasky TM, Goerlitz DS, Trevisan M, Edge SB, Winston J, Berry DL, Kallakury BV, Freudenheim JL, Shields PG. (2015) Adiposity is associated with p53 gene mutations in breast cancer. Breast Cancer Res Treat (Oct), 153(3): 635-645.
Landercasper J, Attai D, Atisha D, Beitsch P, Bosserman L, Boughey J, Carter J, Edge S, Feldman S, Froman J, Greenberg C, Kaufman C, Morrow M, Pockaj B, Silverstein M, Solin L, Staley A, Vicini F, Wilke L, Yang W, Cody H. (2015) Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference. Annals of surgical oncology (Oct), 22(10): 3174-83. doi:10.1245/s10434-015-4759-x
Thirunavukarasu P, Talati C, Munjal S, Attwood K, Edge SB, Francescutti V. (2015) Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival. JAMA Surg (Aug), 150(8): 747-755.
Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH. (2015) Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors. J Clin Oncol (Jul), 33(20): 2254-2261.
Vaz-Luis I, Hughes ME, Cronin AM, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU. (2015) Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study. Cancer (Jun), 121(12): 1937-1948.
Bach PB, Edge SB, House L, Malin J, Mohler JL, Goodman C. (2015) NCCN Roundtable:Value-Based Decision-Making at the Bedside. J Natl Compr Canc Netw (May), 13(5 Sup): 659-661.
Greenberg CC, Habel LA, Hughes ME, Nekhlyudov L, Achacoso N, Acton L, Schrag D, Jiang W, Edge S, Weeks JC, Punglia RS. (2014) Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ. Annals of surgical oncology (Nov), 21(12): 3766-73. doi:10.1245/s10434-014-3802-7
Golubovskaya VM, Ylagan L, Miller A, Hughes M, Wilson J, Wang D, Brese E, Bshara W, Edge S, Morrison C, Cance WG. (2014) High focal adhesion kinase expression in breast carcinoma is associated with lymphovascular invasion and triple-negative phenotype. BMC cancer (Oct), 14: 769. doi:10.1186/1471-2407-14-769
Edge SB. (2014) Quality measurement in breast cancer. J Surg Oncol (Oct), 110(5): 509-517.
McCormick B, Ottesen RA, Hughes ME, Javid SH, Khan SA, Mortimer J, Niland JC, Weeks JC, Edge SB. (2014) Impact of guideline changes on use or omission of radiation in the elderly with early breast cancer: practice patterns at National Comprehensive Cancer Network institutions. J Am Coll Surg (Oct), 219(4): 796-802.
Vaz-Luis I, Ottesen RA, Hughes ME, Mamet R, Burstein HJ, Edge SB, Gonzalez-Angulo AM, Moy B, Rugo HS, Theriault RL, Weeks JC, Winer EP, Lin NU. (2014) Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study. J Clin Oncol (Jul), 32(20): 2142-2150.
Kukar M, Watroba N, Miller A, Kumar S, Edge SB. (2014) Fostering coordinated survivorship care in breast cancer: who is lost to follow-up?. J Cancer Surviv (Jun), 8(2): 199-204.
Connors LM, Voian N, Shi Y, Lally RM, Edge S. (2014) Decision making after BRCA genetic testing. Down the road of transition. Clinical journal of oncology nursing (Jun), 18(3): E58-63.
Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, Benson AB, Bosserman LD, Burstein HJ, Cody H, Hayman J, Perkins CL, Podoloff DA, Giuliano AE. (2014) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (May), 32(13): 1365-1383.
McCann SE, Edge SB, Hicks DG, Thompson LU, Morrison CD, Fetterly G, Andrews C, Clark K, Wilton J, Kulkarni S. (2014) A pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkers. Nutr Cancer (Mar), 66(4): 566-575.
Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O'Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D. (2014) Survivorship: sexual dysfunction (male), version 1.2013. J Natl Compr Canc Netw (Mar), 12(3): 356-363.
Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O'Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D. (2014) Survivorship: sexual dysfunction (female), version 1.2013. J Natl Compr Canc Netw (Feb), 12(2): 184-192.
Singh J, Edge SB, Bonaccio E, Schwert KT, Braun B. (2014) Breast cancer center: improving access to patient care. J Natl Compr Canc Netw (Feb), 12 Su: 28-32.
Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O'Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D. (2014) Survivorship: introduction and definition. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (Jan), 12(1): 34-45.
Tao MH, Hainaut P, Marian C, Nie J, Ambrosone C, Edge SB, Trevisan M, Dorn J, Shields PG, Freudenheim JL. (2013) Association of prediagnostic physical activity with survival following breast cancer diagnosis: influence of TP53 mutation status. Cancer Causes Control (Dec), 24(12): 2177-2186.
Brasky TM, Li Y, Jaworowicz DJ, Potischman N, Ambrosone CB, Hutson AD, Nie J, Shields PG, Trevisan M, Rudra CB, Edge SB, Freudenheim JL. (2013) Pregnancy-related characteristics and breast cancer risk. Cancer Causes Control (Sep), 24(9): 1675-1685.
Ricks-Santi LJ, Nie J, Marian C, Ochs-Balcom HM, Trevisan M, Edge SB, Kanaan Y, Freudenheim JL, Shields PG. (2013) BRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study. Genet Epidemiol (Jul), 37(5): 504-511.
Theriault RL, Carlson RW, Allred C, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Schwartzberg LS, Smith ML, Soliman H, Somlo G, Ward JH, Wolff AC, Zellars R, Shead DA, Kumar R. (2013) Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (Jul), 11(7): 753-760.
Roberts MR, Hong CC, Edge SB, Yao S, Bshara W, Higgins MJ, Freudenheim JL, Ambrosone CB. (2013) Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival. Breast Cancer Res Treat (Jun), 139(3): 873-885.
Hong CC, Yao S, McCann SE, Dolnick RY, Wallace PK, Gong Z, Quan L, Lee KP, Evans SS, Repasky EA, Edge SB, Ambrosone CB. (2013) Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers. Breast Cancer Res Treat (Jun), 139(2): 477-488.
Kurian AW, Edge SB. (2013) Information technology interventions to improve cancer care quality: a report from the American Society of Clinical Oncology Quality Care Symposium. J Oncol Pract (May), 9(3): 142-144.
Edge SB, McKellar D, Stewart AK. (2013) Using the American College of Surgeons cancer registry to drive quality. J Oncol Pract (May), 9(3): 149-151.
Weaver AM, McCann SE, Nie J, Edge SB, Nochajski TH, Russell M, Trevisan M, Freudenheim JL. (2013) Alcohol intake over the life course and breast cancer survival in Western New York exposures and breast cancer (WEB) study: quantity and intensity of intake. Breast Cancer Res Treat (May), 139(1): 245-253.
Cowens-Alvarado R, Sharpe K, Pratt-Chapman M, Willis A, Gansler T, Ganz PA, Edge SB, McCabe MS, Stein K. (2013) Advancing survivorship care through the National Cancer Survivorship Resource Center: developing American Cancer Society guidelines for primary care providers. CA Cancer J Clin (May), 63(3): 147-150.
Tao MH, Marian C, Shields PG, Potischman N, Nie J, Krishnan SS, Berry DL, Kallakury BV, Ambrosone C, Edge SB, Trevisan M, Winston J, Freudenheim JL. (2013) Exposures in early life: associations with DNA promoter methylation in breast tumors. J Dev Orig Health Dis (Apr), 4(2): 182-190.
Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, Wang Q, Dicks E, Lee A, Turnbull C, Rahman N, , Fletcher O, Peto J, Gibson L, Dos Santos Silva I, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Czene K, Irwanto A, Liu J, Waisfisz Q, Meijers-Heijboer H, Adank M, , van der Luijt RB, Hein R, Dahmen N, Beckman L, Meindl A, Schmutzler RK, Müller-Myhsok B, Lichtner P, Hopper JL, Southey MC, Makalic E, Schmidt DF, Uitterlinden AG, Hofman A, Hunter DJ, Chanock SJ, Vincent D, Bacot F, Tessier DC, Canisius S, Wessels LF, Haiman CA, Shah M, Luben R, Brown J, Luccarini C, Schoof N, Humphreys K, Li J, Nordestgaard BG, Nielsen SF, Flyger H, Couch FJ, Wang X, Vachon C, Stevens KN, Lambrechts D, Moisse M, Paridaens R, Christiaens MR, Rudolph A, Nickels S, Flesch-Janys D, Johnson N, Aitken Z, Aaltonen K, Heikkinen T, Broeks A, Veer LJ, van der Schoot CE, Guénel P, Truong T, Laurent-Puig P, Menegaux F, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Zamora MP, Perez JI, Pita G, Alonso MR, Cox A, Brock IW, Cross SS, Reed MW, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Henderson BE, Schumacher F, Le Marchand L, Andrulis IL, Knight JA, Glendon G, Mulligan AM, , , Lindblom A, Margolin S, Hooning MJ, Hollestelle A, van den Ouweland AM, Jager A, Bui QM, Stone J, Dite GS, Apicella C, Tsimiklis H, Giles GG, Severi G, Baglietto L, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Müller H, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Jones M, Figueroa J, Lissowska J, Brinton L, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H, Hamann U, Brüning T, , Radice P, Peterlongo P, Manoukian S, Bonanni B, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Jakubowska A, Lubinski J, Jaworska K, Durda K, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Bogdanova NV, Antonenkova NN, Dörk T, Kristensen VN, Anton-Culver H, Slager S, Toland AE, Edge S, Fostira F, Kang D, Yoo KY, Noh DY, Matsuo K, Ito H, Iwata H, Sueta A, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Shu XO, Lu W, Gao YT, Cai H, Teo SH, Yip CH, Phuah SY, Cornes BK, Hartman M, Miao H, Lim WY, Sng JH, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Shen CY, Hsiung CN, Wu PE, Ding SL, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Blot WJ, Signorello LB, Cai Q, Zheng W, Deming-Halverson S, Shrubsole M, Long J, Simard J, Garcia-Closas M, Pharoah PD, Chenevix-Trench G, Dunning AM, Benitez J, Easton DF. (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nature genetics (Apr), 45(4): 353-61, 361e1-2. doi:10.1038/ng.2563
Mallin K, Palis BE, Watroba N, Stewart AK, Walczak D, Singer J, Barron J, Blumenthal W, Haydu G, Edge SB. (2013) Completeness of American Cancer Registry Treatment Data: implications for quality of care research. J Am Coll Surg (Mar), 216(3): 428-437.
Han D, Nie J, Bonner MR, Ambrosone C, Marian C, Shields P, Trevisan M, Edge SB, Freudenheim JL. (2013) Clustering of place of birth for women with breast cancer: differences by tumor characteristics. Cancer Causes Control (Mar), 24(3): 587-594.
Edge SB. (2013) The challenge of quality in breast care: beyond accreditation. J Oncol Pract (Mar), 9(2): 71-72.
Lally RM, Hydeman JA, Schwert KT, Edge SB. (2013) Unsupportive social interactions in the weeks immediately following breast cancer diagnosis. J Psychosoc Oncol (Jan), 31(4): 468-488.
Vandergrift JL, Niland JC, Theriault RL, Edge SB, Wong YN, Loftus LS, Breslin TM, Hudis CA, Javid SH, Rugo HS, Silver SM, Lepisto EM, Weeks JC. (2013) Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst (Jan), 105(2): 104-112.
Edge SB. (2013) Advances in breast surgery, 2002-2012. J Natl Compr Canc Netw (Jan), 11(1): 53-59.
Mandl KD, Edge S, Malone C, Marsolo K, Natter MD. (2013) Next-generation registries: fusion of data for care, and research. AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science (Jan), 2013: 164-7.
Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH. (2012) Time to diagnosis and breast cancer stage by race/ethnicity. Breast Cancer Res Treat (Dec), 136(3): 813-821.
Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong YN, Lee SJ, Hassett MJ. (2012) Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ. Cancer (Dec), 118(24): 6022-6030.
Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong YN, Blayney DW, Niland JC, Winer EP, Weeks JC. (2012) Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer (Nov), 118(22): 5463-5472.
Carlson RW, Allred DC, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Soliman H, Somlo G, Theriault RL, Ward JH, Wolff AC, Zellars R, Kumar R, Shead DA. (2012) Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (Jul), 10(7): 821-829.
Ademuyiwa FO, Bshara W, Attwood K, Morrison C, Edge SB, Karpf AR, James SA, Ambrosone CB, O'Connor TL, Levine EG, Miliotto A, Ritter E, Ritter G, Gnjatic S, Odunsi K. (2012) NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer. PLoS One (Jun), 7(6): 38783-38783.
Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, Hudis CA, Marcom PK, Pettinga JE, Share D, Theriault R, Wong YN, Vandergrift JL, Niland JC, Weeks JC. (2012) Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol (Jun), 30(18): 2218-2226.
Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM. (2012) The effect of age on delay in diagnosis and stage of breast cancer. Oncologist (May), 17(6): 775-782.
Li Y, Brasky TM, Nie J, Ambrosone CB, McCann SE, Shields PG, Trevisan M, Edge SB, Freudenheim JL. (2012) Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev (Jan), 21(1): 239-242.
Wilson JP, Miller A, Edge SB. (2012) Breast education in general surgery residency. Am Surg (Jan), 78(1): 42-45.
McCann SE, Hootman KC, Weaver AM, Thompson LU, Morrison C, Hwang H, Edge SB, Ambrosone CB, Horvath PJ, Kulkarni SA. (2012) Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics. J Nutr (Jan), 142(1): 91-98.
Lally RM, Hydeman JA, Schwert K, Henderson H, Edge SB. (2012) Exploring the first days of adjustment to cancer: a modification of acclimating to breast cancer theory. Cancer Nurs (Jan), 35(1): 3-18.
Dhillon J, Edge S, Kasznica J, Nava ME, Ankola A, Ademuyiwa F. (2012) Importance of biosy of a presumed solitary skeletal metastasis: enchondroma in a breast cancer patient. The breast journal (Jan), 18(2): 172-4.
Brewster AM, Etzel C, Zhou R, Wong Y, Edge S, Blayney DW, Wilson J, Hudis C, Ottesen R, Hughes ME, Weeks JC, Theriault RL. (2011) The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers. Breast cancer research and treatment (Dec), 130(3): 897-904. doi:10.1007/s10549-011-1516-0
Tao MH, Marian C, Shields PG, Nie J, McCann SE, Millen A, Ambrosone C, Hutson A, Edge SB, Krishnan SS, Xie B, Winston J, Vito D, Russell M, Nochajski TH, Trevisan M, Freudenheim JL. (2011) Alcohol consumption in relation to aberrant DNA methylation in breast tumors. Alcohol (Nov), 45(7): 689-699.
Khoury T, Kulkarni S, Morrison C, Bshara W, Zakharia Y, Edge S. (2011) HER2 testing: how to reach a high concordance rate between immunohistochemistry and fluorescence in situ hybridization. Applied immunohistochemistry & molecular morphology : AIMM (Oct), 19(5): 424-30.
Tao MH, Mason JB, Marian C, McCann SE, Platek ME, Millen A, Ambrosone C, Edge SB, Krishnan SS, Trevisan M, Shields PG, Freudenheim JL. (2011) Promoter methylation of E-cadherin, p16, and RAR-Î²(2) genes in breast tumors and dietary intake of nutrients important in one-carbon metabolism. Nutr Cancer (Sep), 63(7): 1143-1150.
Tao MH, Marian C, Nie J, Ambrosone C, Krishnan SS, Edge SB, Trevisan M, Shields PG, Freudenheim JL. (2011) Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study. Am J Clin Nutr (Sep), 94(3): 831-838.
Ademuyiwa FO, Groman A, O'Connor T, Ambrosone C, Watroba N, Edge SB. (2011) Impact of body mass index on clinical outcomes in triple-negative breast cancer. Cancer (Sep), 117(18): 4132-4140.
Dominici L, Najita J, Hughes M, Niland J, Marcom P, Wong YN, Carter B, Javid S, Edge S, Burstein H, Golshan M. (2011) Surgery of the primary tumor does not improve survival in stage IV breast cancer. Breast cancer research and treatment (Sep), 129(2): 459-65. doi:10.1007/s10549-011-1648-2
Marian C, Ochs-Balcom HM, Nie J, Kallakury BV, Ambrosone CB, Trevisan M, Edge S, Shields PG, Freudenheim JL. (2011) FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors. International journal of cancer (Aug), 129(3): 702-12. doi:10.1002/ijc.25686
Greenberg CC, Lipsitz SR, Hughes ME, Edge SB, Theriault R, Wilson JL, Carter WB, Blayney DW, Niland J, Weeks JC. (2011) Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. Ann Surg (Aug), 254(2): 339-345.
Roberts MR, Shields PG, Ambrosone CB, Nie J, Marian C, Krishnan SS, Goerlitz DS, Modali R, Seddon M, Lehman T, Amend KL, Trevisan M, Edge SB, Freudenheim JL. (2011) Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. Carcinogenesis (Aug), 32(8): 1223-1230.
Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Goerlitz DS, Trevisan M, Shields PG, Freudenheim JL. (2011) Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes Control (Jul), 22(7): 965-975.
Ricks-Santi LJ, Sucheston LE, Yang Y, Freudenheim JL, Isaacs CJ, Schwartz MD, Dumitrescu RG, Marian C, Nie J, Vito D, Edge SB, Shields PG. (2011) Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk. BMC Cancer (Jun), 11: 278-278.
Erwin DP, Erwin DO, Ciupak G, Hellenthal N, Sofi MJ, Guru KA, Edge SB. (2011) Challenges and implementation of a women's breast health initiative in rural Kashmir. Breast (Apr), 20 Su: 46-50.
Ademuyiwa FO, Miller A, O'Connor T, Edge SB, Thorat MA, Sledge GW, Levine E, Badve S. (2011) The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort. Breast cancer research and treatment (Apr), 126(3): 797-802.
Wong YN, Ottesen RA, Hughes ME, Niland JC, Theriault R, Edge SB, Blayney D, Weeks JC. (2011) Continued use of trastuzumab beyond disease progression in the national comprehensive cancer network: should we practice ahead of the evidence?. Oncologist (Mar), 16(5): 559-565.
Wasif N, Cormier JN, Ko CY, McCahill LE, Edge SB, Wong SL, Anthony T, Kollmorgen D, Marcus SG, Bleznak A, Leong SP. (2011) Quality measurement in cancer care delivery. Ann Surg Oncol (Mar), 18(3): 611-618.
Yao S, Sucheston LE, Millen AE, Johnson CS, Trump DL, Nesline MK, Davis W, Hong CC, McCann SE, Hwang H, Kulkarni S, Edge SB, O'Connor TL, Ambrosone CB. (2011) Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One (Feb), 6(2): 17251-17251.
Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Sachdev J, Smith ML, Somlo G, Ward JH, Wolff AC, Zellars R. (2011) Invasive breast cancer. J Natl Compr Canc Netw (Feb), 9(2): 136-222.
Fedewa SA, Edge SB, Stewart AK, Halpern MT, Marlow NM, Ward EM. (2011) Race and ethnicity are associated with delays in breast cancer treatment (2003-2006). J Health Care Poor Underserved (Feb), 22(1): 128-141.
Brasky TM, Bonner MR, Moysich KB, Ochs-Balcom HM, Marian C, Ambrosone CB, Nie J, Tao MH, Edge SB, Trevisan M, Shields PG, Freudenheim JL. (2011) Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat (Feb), 126(1): 157-165.
Ademuyiwa FO, Edge SB, Erwin DO, Orom H, Ambrosone CB, Underwood W. (2011) Breast cancer racial disparities: unanswered questions. Cancer Res (Feb), 71(3): 640-644.
Wilson JP, Mattson D, Edge SB. (2011) Is there a need for axillary dissection in breast cancer?. Journal of the National Comprehensive Cancer Network : JNCCN (Feb), 9(2): 225-30.
Khoury T, Zakharia Y, Tan W, Kulkarni S, Liu W, Zhang S, Wilding GE, Edge S. (2011) Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsy. The breast journal (Jan), 17(2): 180-6.
Khoury T. (2011) . HER2 testing: How to reach a high concordance rate between immunohistochemistry and fluorescence in situ hybridization. App Immunohistochem (Jan)424-430.
Ahn HS, Lee HJ, Hahn S, Kim WH, Lee KU, Sano T, Edge SB, Yang HK. (2010) Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer (Dec), 116(24): 5592-5598.
Edge SB, Zwelling LA, Hohn DC. (2010) The anticipated and unintended consequences of the patient protection and affordable care act on cancer research. Cancer J (Nov), 16(6): 606-613.
Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Somlo G, Topham NS, Ward JH, Winer EP, Wolff AC. (2010) Breast cancer: noninvasive and special situations. J Natl Compr Canc Netw (Oct), 8(10): 1182-1207.
Fedewa SA, Ward EM, Stewart AK, Edge SB. (2010) Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. J Clin Oncol (Sep), 28(27): 4135-4141.
Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Trevisan M, Shields PG, Freudenheim JL. (2010) Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer causes & control : CCC (Sep), 21(9): 1503-12. doi:10.1007/s10552-010-9579-5
Fedewa SA, Ward E, Stewart AK, Edge SB. (2010) Delays in Adjuvant Chemotherapy Treatment Among Breast Cancer Patients are More Likely in African American and Hispanic Populations: A National Cohort Study 2004-2006. J Clin Oncol (Aug).
Brasky TM, Bonner MR, Moysich KB, Ochs-Balcom HM, Marian C, Ambrosone CB, Nie J, Tao MH, Edge SB, Trevisan M, Shields PG, Freudenheim JL. (2010) Genetic Variants in COX-2 Non-Steroidal Anti-Imflammatory Drugs and Breast Cancer Risk: The Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat. (Jul).
McCann SE, Thompson LU, Nie J, Dorn J, Trevisan M, Shields PG, Ambrosone CB, Edge SB, Li HF, Kasprzak C, Freudenheim JL. (2010) Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast cancer research and treatment (Jul), 122(1): 229-35. doi:10.1007/s10549-009-0681-x
Garber JE, Halabi S, Tolaney SM, Kaplan E, Archer L, Atkins JN, Edge S, Shapiro CL, Dressler L, Paskett ED, Kimmick G, Orcutt J, Scalzo A, Winer E, Levine E, Shahab N, Berliner N, . (2010) Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer. Journal of the National Cancer Institute (Jul), 102(13): 942-9. doi:10.1093/jnci/djq211
Mandelblatt JS, Sheppard VB, Hurria A, Kimmick G, Isaacs C, Taylor KL, Kornblith AB, Noone AM, Luta G, Tallarico M, Barry WT, Hunegs L, Zon R, Naughton M, Winer E, Hudis C, Edge SB, Cohen HJ, Muss H, . (2010) Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (Jul), 28(19): 3146-53. doi:10.1200/JCO.2009.24.3295
Meguerditchian AN, Stewart A, Roistacher J, Watroba N, Cropp M, Edge SB. (2010) Claims data linked to hospital registry data enhance evaluation of the quality of care of breast cancer. Journal of surgical oncology (Jun), 101(7): 593-9.
Platek ME, Shields PG, Tan D, Marian C, Bonner MR, McCann SE, Nie J, Wilding GE, Ambrosone C, Millen AE, Trevisan M, Russell M, Nochajski TH, Edge SB, Winston J, Freudenheim JL. (2010) Alcohol consumption and breast tumor mitochondrial DNA mutations. Breast cancer research and treatment (Jun), 121(2): 453-60. doi:10.1007/s10549-009-0587-7
Mandelblatt JS, Sheppard VS, Hurria A, Kimmick G, Isaacs C, Taylor KL, Kornblith AB, Noone AM, Luta G, Tallico M, Barry WT, Hunegs L, Zon R, Naughton M, Winer E, Hudis C, Edge SB, Cohen JH, Muss H. (2010) Breast Cancer Adjuvant Chemotherapy Decisions in Older Women: The Role of Patient Preference and Interactions with Physicians. J Clin Oncol. (Jun).
Brasky TM, Bonner MR, Moysich KB, Amborosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Trevisan M, Shields PG, Freudenheim JL. (2010) Non-Steroidal Anti-Inflammatory Drug (NSAID) Use and Breast Cancer Risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control (May).
Alderman AK, Collins ED, Schott A, Hughes ME, Ottesen RA, Theriault RL, Wong YN, Weeks JC, Niland JC, Edge SB. (2010) The impact of breast reconstruction on the delivery of chemotherapy. Cancer (Apr), 116(7): 1791-800. doi:10.1002/cncr.24891
Edge SB. (2010) Commentary: "help the doctor"-the culture shift to 21st century care management. J Oncol Pract (Mar), 6(2): 89-90.
Edge SB. (2010) "Help the Doctor" - Information Systems to Improve Cancer Care in the 21st Century. Journal of Oncology Practice (Mar)89-90.
Edge SB. (2010) "Help the Doctor" - The Cultural Shift to 21st Century Care Management. J Oncol Pract. (Jan), 6(2): 89-90.
Platek ME, Shields PG, Tan D, Marian C, Bonner MR, McCann SE, Nie J, Wilding GE, Ambrosone C, Millen AE, Trevisan M, Russell M, Nochajski TH, Edge SB, Winston J, Freudenheim JL. (2010) Alcohol Consumption and Breast Tumor Mitochondrial DNA Mutations. Breast Cancer Res Treat (Jan), 121(2): 453-460.
Edge SB, Comptom C. (2010) Cancer Staging Revisions for the 7th Edition AJCC Cancer Staging Manual. Ann Surg Oncol (Jan), 17(6): 1471-1474.
Meguerditchian AN, Stewart A, Roistacher J, Watroba N, Cropp M, Edge SB. (2010) Claims Data Linked to Hospital Registry Data Enhance Evaluation of the Quality of Care of Breast Cancer. Journal of Surgica Oncology (Jan), 101(7): 593-599.
Garber JE, Halbai S, Tolaney SM, Kaplan E, Archer L, Atkins JN, Edge SB, Shapiro CL, Dressler L, Paskett EM, Kimick G, Orcutt J, Scalzo A, Winer E, Levine E, Shahab N, Berliner N. (2010) Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer. J Natl Cancer Inst. (Jan), 102(13).
McCann SE, Thompson LU, Nie J, Dorn J, Trevisan M, Shields PG, Ambrosonee, Edge SB, Li HG, Kasprzak C, Freudenheim JL. (2010) Dietary Lignan Intakes in Relation to Survival Among Women with Breast Cancer: The Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat (Jan), 122(1): 229-235.
Alderman AK, Collins ED, Schott A, Hughes ME, Ottesen RA, Theriault RL, Wong YN, Weeks JC, Niland JC, Edge SB. (2010) The Impact of Breast Reconstruction on the Delivery of Chemotherapy. Cancer (Jan), 116: 1791-1800.
McLaughlin CC, Lillquist PP, Edge SB. (2009) Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005. Cancer (Dec), 115(23): 5404-5412.
Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ, Gown A, Hammond ME, Iglehart JD, Moench S, Pierce LJ, Ravdin P, Schnitt SJ, Wolff AC. (2009) NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. Journal of the National Comprehensive Cancer Network : JNCCN (Sep), 7 Suppl 6: S1-S21; quiz S22-3.
Platek ME, Shields PG, Marian C, McCann SE, Bonner MR, Nie J, Ambrosone CB, Millen AE, Ochs-Balcom HM, Quick SK, Trevisan M, Russell M, Nochajski TH, Edge SB, Freudenheim JL. (2009) Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (Sep), 18(9): 2453-9. doi:10.1158/1055-9965.EPI-09-0159
Tao MH, Shields PG, Nie J, Millen A, Ambrosone CB, Edge SB, Krishnan SS, Marian C, Xie B, Winston J, Vito D, Trevisan M, Freudenheim JL. (2009) DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat (Apr), 114(3): 559-568.
Taylor ME, Haffty BG, Rabinovitch R, Arthur DW, Halberg FE, Strom EA, White JR, Cobleigh MA, Edge SB. (2009) ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast. International journal of radiation oncology, biology, physics (Mar), 73(4): 997-1002.
Tao MH, Shields PG, Nie J, Marian C, Ambrosone CB, McCann SE, Platek M, Krishnan SS, Xie B, Edge SB, Winston J, Vito D, Trevisan M, Freudenheim JL. (2009) DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (Mar), 18(3): 998-1002. doi:10.1158/1055-9965.EPI-08-0916
Lehman CD, DeMartini W, Anderson BO, Edge SB. (2009) Indications for breast MRI in the patient with newly diagnosed breast cancer. Journal of the National Comprehensive Cancer Network : JNCCN (Feb), 7(2): 193-201.
Svahn TH, Niland JC, Carlson RW, Hughes ME, Ottesen RA, Theriault RL, Edge SB, Schott AF, Bookman MA, Weeks JC. (2009) Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer. Journal of the National Comprehensive Cancer Network : JNCCN (Feb), 7(2): 115-21.
Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. (2009) Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data. Cancer (Feb), 115(4): 716-724.
Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC. (2009) Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (Feb), 7(2): 122-192.
Platek ME, Shields PG, Marian C, McCann SE, Bonner MR, Nie J, Ambrosone CB, Millen AE, Ochs-Balcom HM, Quick DK, Trevisan M, Russell M, Nochajski TH, Edge SB, Freudenheim JL. (2009) Alcohol Consumption and Genetic Variation in Methylenetetrahydrofolate Reductase and 5-Methyltetrahyrofolate-Homocysteine Methyltransferase in Relation to Breast Cancer Risk. Cancer Eipdemiol Biomarkers (Jan), 18(9): 245-2359.
Taylor ME, Haffty BG, Rabinovitch R, Arthur DW, Halberg FE, Strom EA, White JR, Cobleigh MA, Edge SB. (2009) ACR Appropriateness Criteria on Postmastectomy Radiotherapy Expert Panel on Radiation Oncology-Breast. Int J Radiat Oncol Biol Phys. (Jan), 73(4): 997-1002.
Tao MH, Shields PG, Nie J, Millen A, Ambrosone DB, Edge SB, Krishnan SS, Marian C, Xie B, Winston J, Vito D, Trevisan M, Freudenheim JL. (2009) DNA Hypermethylation and Clinicopathological Features in Breast Cancer; The Western New York Exposures and Cancer (WEB) Study. Breast Cancer Res Treat (Jan), 114: 559-568.
Tao MH, Shields PG, Nie J, Marian C, Ambrosone B, McCann SE, Platek, Krishnan SS, Xie B, Edge SB, Winston J, Vito D, Treisan M, Freudenheim JL. (2009) DNA Promoter Methylation in Breast Tumors: No Association with Genetic Polymorphisms in MTHFR and MTR. Cancer Epidemiol Biomarkers Prev. (Jan), 18: 998-1002.
Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. (2009) Epidemiology and End Results-Medicare Data. Cancer (Jan), 115: 716-724.
Lehman CD, MeMartini W, Anderson BO, Edge SB. (2009) Indications for Breast MRI in the Patient with Newly Diagnosed Breast Cancer. J Natl Compr Netw. (Jan), 7: 193-201.
McLaughlin CC, Lillquist PP, Edge SB. (2009) Surveillance of Prophylactic Mastectomy: Trends in Use from 1995-2005. Cancer (Jan), 115(23): 5404-5412.
Edge SB. (2009) Nipple-Sparing Mastectomy: How Often is the Nipple Involved?. J Clin Oncol (Jan), 27(30): 4930-4932.
Svahn TH, Niland JC, Carlson RW, Hughes ME, Ottesen RA, Theriault RL, Edge SB, Schott AF, Bookman MA, Weeks JC. (2009) Predictors and Temporal Trends of Adjuvant Aromatase Inhibitor Use in Breast Cancer. J Natl Compr Canc Netw (Jan), 7: 115-121.
Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ, Bown A, Hammond ME, Iglehart JD, Moench Sq, Pierce LJ, Ravdin P, Schnitt SJ, Wolff AC. (2009) NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. J Natl Comp Cancer Network (Jan), 7.
Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC. (2009) NCCN Breast Cancer Clinical Practice Guidelines Panel. Breast Cancer. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. (Jan), 7: 122-192.
Punglia RS, Hughes ME, Edge SB, Theriault RL, Bookman MA, Wilson JL, Ottesen RA, Niland JC, Weeks JC. (2008) Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network. Int J Radiat Oncol Biol Phys (Dec), 72(5): 1434-1440.
Hassett MJ, Hughes ME, Niland JC, Edge SB, Theriault RL, Wong YN, Wilson J, Carter WB, Blayney DW, Weeks JC. (2008) Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer. J Clin Oncol (Dec), 26(34): 5553-5560.
Wong SL, McCahill LE, Edge SB, Askew RL, Beitsch PD, Kollmorgen DR, Anthony T, Petrelli NJ, Leong SP, Cormier JN. (2008) Getting to better cancer care: results of a society of surgical oncology survey. Ann Surg Oncol (Sep), 15(9): 2363-2371.
Hassett MJ, Hughes ME, Niland JC, Ottesen R, Edge SB, Bookman MA, Carlson RW, Theriault RL, Weeks JC. (2008) Selecting high priority quality measures for breast cancer quality improvement. Medical care (Aug), 46(8): 762-70. doi:10.1097/MLR.0b013e318178ead3
Desch CE, McNiff KK, Schneider EC, Schrag D, McClure J, Lepisto E, Donaldson MS, Kahn KL, Weeks JC, Ko CY, Stewart AK, Edge SB. (2008) American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol (Jul), 26(21): 3631-3637.
Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL. (2008) Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (May), 17(5): 1082-7.
White JR, Halberg FE, Rabinovitch R, Green S, Haffty BG, Solin LJ, Strom EA, Taylor ME, Edge SB. (2008) American College of Radiology Appropriateness Criteria on Conservative Surgery and Radiation: Stages I and II Breast Carcinoma. J Am Coll Radiol. (Jan), 5(6): 701-713.
Hassett JM, Hughes ME, Niland JC, Edge SB, Theriault RL, Wong YN, Wilson J, Carter WB, Blayney DW, Weeks JC. (2008) Chemotherapy Use for Hormone Receptor-Positive Lymph Node-Negative Breast Cancer. J Clin Oncol (Jan), 26: 5553-5560.
Wong SL, McCahill LE, Edge SB, Askew RL, Beitsch PD, Kollmorgen DR, Anthony T, Petrelli NJ, Cormier JN. (2008) Getter to Better Cancer Care: Results of a Society of Surgical Oncology Survey. Ann Surg Oncol. (Jan), 15(9): 2363-2371.
Punglia RS, Hughes ME, Edge SB, Theriault RL, Bookman MA, Wilson JL, Ottesen RA, Niland JC, Weeks JC. (2008) Factors Associated with Guideline-Concordant Use of Radiation Therapy After Mastectomy in the National Comprehensive Cancer Network. Int J Radiat Oncol Biol Phys (Jan), 72: 1434-1440.
Edge SB. (2008) Early Adoption and Disturbing Disparities in Sentinel Node Biopsy in Breast Cancer. J Natl Cancer Inst. (Jan), 100(7): 449-450.
Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL. (2008) Effect Modification by Catalase Genotype Suggests a Role for Oxidative Stress in the Association of Hormone Replacement Therapy with Postmenopausal Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. (Jan), 17(5): 1082-1087.
Desch CE, McNiff KK, Schneider EC, Schrag D, McClure J, Lepisto E, Donaldson MS, Kahn KL, Weeks JC, Ko CY, Stewart AK, Edge SB. (2008) The ASCO/NCCN Quality Measures. J Clin Oncol (Jan), 26(21): 3631-3637.
Hassett MJ, Hughes ME, Niland JC, Ottesen R, Edge SB, Bookman MA, Carlson RW, Theriault RL, Weeks JC. (2008) Selecting High Priority Quality Measures for Breast Cancer Quality Improvement. Medical Care (Jan), 46(8): 762-770.
Nie J, Beyea J, Bonner MR, Han D, Vena JE, Rogerson P, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL. (2007) Exposure to traffic emissions throughout life and risk of breast cancer: the Western New York Exposures and Breast Cancer (WEB) study. Cancer Causes Control (Nov), 18(9): 947-955.
Varadarajan R, Edge SB, Yu J, Watroba N, Janarthanan BR. (2007) Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis. Oncology (Aug), 71(5-6): 456-459.
Eberl MM, Watroba N, Reinhardt M, Pomerantz J, Serghany J, Broffman G, Fox CH, Mahoney MC, Edge SB. (2007) Linked claims and medical records for cancer case management : evaluation of mammography abnormalities. Cancer (Aug), 110(3): 518-524.
Yen TW, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Theriault RL, Weeks JC. (2007) Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ. J Clin Oncol (Aug), 25(22): 3251-3258.
McCann SE, McCann WE, Hong CC, Marshall JR, Edge SB, Trevisan M, Muti P, Freudenheim JL. (2007) Dietary patterns related to glycemic index and load and risk of premenopausal and postmenopausal breast cancer in the Western New York Exposure and Breast Cancer Study. Am J Clin Nutr (Aug), 86(2): 465-471.
Podoloff DA, Advani RH, Allred AC, Edge SB, et.at. (2007) NCCN Task Force Report: Positron Emission Tomography (PET) Computed Tomography (CT) Scanning in Cancer. J Natl Compr Canc Netw (May).
Podoloff DA, Advani RH, Allred C, Benson AB, Brown E, Burstein HJ, Carlson RW, Coleman RE, Czuczman MS, Delbeke D, Edge SB, Ettinger DS, Grannis FW, Hillner BE, Hoffman JM, Kiel K, Komaki R, Larson SM, Mankoff DA, Rosenzweig KE, Skibber JM, Yahalom J, Yu JM, Zelenetz AD. (2007) NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw (May), 5 Sup: 1-22.
Carlson RW, Anderson BO, Burstein HJ, Carter WB, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Ljung BM, Kiel K, Marks LB, McCormick B, Nabell LM, Pierce LJ, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Ward JH, Winer EP, Wolff AC. (2007) Invasive breast cancer. J Natl Compr Canc Netw (Mar), 5(3): 246-312.
Eberl MM, Watroba N, Reinhardt M, Pomerantz J, Serghany J, Grovman G, Fox Ch, Mahoney MC, Edge SB. (2007) Linked Claims and Medical Records for Cancer Case Management: Evaluation of Mammography Abnormalities. Cancer (Jan), 110: 518-524.
Carlson RW, Anderson BO, Burstein HJ, Edge SB, Et al. (2007) Invasive Breast Cancer (NCCN Guidelines). J Natl Compr Canc Netw (Jan), 5(2): 246-312.
Varadarajan R, Edge SB, Yu J, Watroba N, Janarthanan BR. (2007) Prognosis of Occult Breast Carcinoma Presenting as Isolated Axillary Metastases. Oncology (Jan), 71(5-6): 456-459.
McCann SE, McCann WE, Hong CC, Marshall JR, Edge SB, Trevisan M, Muti P, Freudenheim JL. (2007) Dietary Patterns Related to Glycemic Index and Load and Risk of Pre-And-Postmenopausal Breast Cancer in the Western New York Exposures and Breast Cancer (WEB) Study. American Journal of Clinical Nutrition (Jan), 86(2): 465-312.
Yen TW, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Therialt RL, Weeks JC. (2007) Impact of Randomized Clinicl Trial Results on the Use of Tamoxifen Following Breast Surgery for Ductal Carcinoma in Situ in the National Comprehensive Cancer Network. Journal of Clinical Oncology. (Jan), 25(22): 3251-3258.
Nie J, Beyea J, Bonner MR, Han D, Vena JE, Rogerson P, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL. (2007) Exposure to Traffic Emmisions Throughout Life and Risk of Breast Cancer. The Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Controls (Jan), 18(9): 947-955.
Fernando SA, Edge SB. (2007) Evidence and Controversies in the Use of Post-Mastectomy Radiation. Journal of the National Comprehensive Cancer Network (Jan), 5: 331-337.
McCann SE, Kulkarni S, Trevisan M, Vito D, Nie J, Edge SB, Muti P, Freudenheim JL. (2006) Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Res Treat (Oct), 99(3): 309-311.
Eberl MM, Fox CH, Edge SB, Carter CA, Mahoney MC. (2006) BI-RADS classification for management of abnormal mammograms. J Am Board Fam Med (Mar), 19(2): 161-164.
Palesty JA, Foster JM, Hurd TC, Watroba N, Rezaishiraz H, Edge SB. (2006) Axillary Recurrence In Women with a Negative Sentinel Lymph Node and No Axillary Dissection in Breast Cancer. J Surg Oncol. (Feb), 93(2): 129-132.
Christian CK, Niland J, Edge SB, Ottesen RA, Hughes ME, Theriault R, Wilson J, Hergrueter CA, Weeks JC. (2006) A Multi-Institutional Analysis of the Socioeconomic Determinants of Breast Reconstruction: A Study of the National Comprehensive Cancer Network. Ann Surg (Feb), 243(2): 241-249.
James TA, Edge SB. (2006) Sentinel lymph node in breast cancer. Curr Opin Obstet Gynecol (Feb), 18(1): 53-58.
Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, Bookman MA, Weeks JC. (2006) The Use of Radiation as a Component of Breast Conservation Therapy in National Comprehensive Cancer Network Centers. J Clin Oncol. (Jan), 24(3): 361-369.
McCann SE, Kulkanri W, Trevisan M, Vito D, Nie J, Edge SB, Muti P, Freudenheim JL. (2006) Dietary Lignan Intakes and Risk of Breast Cancer by Estrogen Receptor Status. Breast Cancer Research and Treatment. (Jan), 99(3): 309-311.
Stoler DL, Bartos JD, wede H, Edge SB, Winston JS, Wiseman SM, Anderson GR. (2006) GENOMIC Instability in Invasive Breast Carcinoma Measured by Inter-Simple Sequence Repeat PCR. Breast Cancer Res Treat (Jan), 97(1): 107-110.
Bonner MR, Nie J, Han D, Vena JE, Rogerson P, Muti P, Trevisan M, Edge SB, Freudenheim JL. (2005) Secondhand smoke exposure in early life and the risk of breast cancer among never smokers (United States). Cancer Causes Control (Aug), 16(6): 683-689.
Bonner MR, Nie J, Han D, Vena JE, Rogerson P, Muti P, Trevisan M, Edge SB, Freudenheim JL. (2005) Secondhand Smoke Exposure in Early Life and the Risk of Breast Cancer Among Never Smokers (US). Cancer Causes Control (Jan), 16(6): 683-689.
Carlson RW, Anderson BO, Burstein HJ, Cox CE, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis C, Jahanzeb M, Ljung BM, Marks LB, McCormick B, Nabell LM, Pierce LJ, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Ward JH, Winer EP, Wolff AC. (2005) National Comprehensive Cancer Network. Breast Cancer. Journal of Natl Conr Cnc Netw (Jan), 3(3): 238-289.
Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein JH, Cochran AJ, Cody HS, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP. (2005) American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer. Journal of Clinical Oncology (Jan), 23(30): 7703-7720.
Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KL, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR. (2005) American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Women with Hormone Receptor-Positive. Breast Cancer: Status Report 2004 (Jan), 23(3): 619-629.
Bonner MR, Han D, Nie J, Rogerson R, Vena JE, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL. (2005) Breast Cancer Risk and Exposure in Early Life to Polycyclic Aromatic Hydrocarbons Using Total Suspended Particulates as a Proxy Measure. Cancer Epidemiol Biomarkers Prev. (Jan), 14(1): 53-60.
Han D, Rogerson PA, Nie J, Bonner MR, Vena JE, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL. (2004) Geographic clustering of residence in early life and subsequent risk of breast cancer (United States). Cancer Causes Control (Nov), 15(9): 921-929.
McCann SE, Muti P, Vito D, Edge SB, Trevisan M, Freudenheim JL. (2004) Dietary lignan intakes and risk of pre- and postmenopausal breast cancer. Int J Cancer (Sep), 111(3): 440-443.
Carlson RW, Edge SB. (2004) Update: NCCN breast cancer clinical practice guidelines. J Natl Compr Canc Netw (Sep), 2 Sup: 0-1.
Hinrichs CS, Gibbs JF, Driscoll D, Kepner J, Wilkinson NW, Edge SB, Fassl KA, Muir R, Kraybill WG. (2004) The Effectiveness of Complete Decongestive Physiotherapy for the Treatment of Lymphedema Following Groin Dissection for Melanoma. J Surg Onc (Jan), 85(4): 187-192.
Hinrichs CS, Watroba JL, Hurd TC, Rezaishiraz H, Giese W, Edge SB. (2004) Lymphedema Secondary to Postmastectomy Radiation: Incidence and Risk Factors. Ann Surg Onc (Jan), 11(6): 573-580.
McCann SE, Ip C, Ip MM, McGuire MK, Muti P, Edge SB, Trevisan M, Freudenheim JL. (2004) Dietary Intake of Conjugated Linoleic Acids and Risk of Premenopausal and Postmenopausal Breast Cancer, Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiol Biomarkers Prev. (Jan), 13(9): 1480-1484.
McCann SE, Muti P, Vito D, Edge SB, Trevisan M, Freudenheim JL. (2004) Dietary Lignan Intake and Risk of Pre- And Postmenopausal Breast Cancer. Int J Cancer (Jan), 111(3): 440-443.
Han D, Rogerson PA, Nie J, Bonner MR, Vena JE, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL. (2004) Geographic Clustering of Residence in Early Life and Subsequent Risk of Breast Cancer (USA). Cancer Causes Control (Jan), 15(9): 921-929.
Edge SB, Niland JC, Bookman MA, Theriault RL, Ottesen R, Lepisto E, Weeks JC. (2003) Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst (Oct), 95(20): 1514-1521.
Recht A, Edge SB. (2003) Evidence-based indications for postmastectomy irradiation. Surg Clin North Am (Aug), 83(4): 995-1013.
Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark GM, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL. (2003) Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am (Aug), 83(4): 803-819.
Charles M, Edge SB, Winston JS, Hurd TC, Driscoll DL, Stomper PC. (2003) Effect of stereotactic core needle biopsy on pathologic measurement of tumor size of T1 invasive breast carcinomas presenting as mammographic masses. Cancer (May), 97(9): 2137-2141.
Edge SB, Sheldon DG. (2003) Counterpoint: sentinel lymph node biopsy is not indicated for ductal carcinoma in situ. J Natl Compr Canc Netw (Apr), 1(2): 207-212.
Swede H, Moysich KB, Winston JS, Hurd TC, Edge SB, Romero-Gutierrez M, Brooks JS, Michalek AM. (2003) Variation of the prognostic significance of HER-2 expression in breast cancer according to tumor size. Breast J (Mar), 9(2): 98-105.
Swede H, Moysich KB, Winston JS, Hurd TC, Edge SB, Gutierriz-Romero M, Brooks JSJ, Michalek AM. (2003) Variation of the Prognostic Significance of HER2 Expression in Breast Cancer According to Tumor Size. The Breast Journal (Jan), 9(2): 99-106.
Edge SB, Sheldon DG. (2003) Sentinel Node Biopsy is Not Indicated in Ductal Carcinoma in Situ. J Natl Comp Cancer Network (Jan), 1: 207-212.
Charles M, Edge SB, Winston JS, Hurd TC, Driscoll DL, Stomper PC. (2003) The Effect of Stereotactic Core Needle Biopsy on Pathologic Measurement of Tumor Size of T1Invasive Breast Cancers Presenting as Mammographic Masses. Cancer (Jan), 97: 2137-2141.
Lamonica D, Edge S, Hurd TC, Proulx G, Stomper PC. (2003) Mammographic and clinical predictors of drainage patterns in breast lymphoscintigrams obtained during sentinel node procedures. Clinical Nuclear Medicine (Jan), 28(7): 558-564.
Stomper P, Geradts J, Edge SB, Levine E. (2003) Mammographic Predictors of the Presence and Size of Invasive Carcinomas Associated With Malignant Microcalcification Lesions Without a Mass. AJR Am J Roent (Jan), 181: 1679-1684.
Wilkinson NW, Shahryarinejad A, Winston JS, Watroba N, Edge SB. (2003) Concordance with breast cancer pathology reporting practice guidelines. J Am Coll Surg (Jan), 196(1): 38-43.
Winer EP, Hudis C, Burstein JH, Bryant J, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gelber R, BralowJ, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP. (2003) American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting. J Clin Oncol (Jan), 21: 1597-1599.
Edge S, Niland J, Bookman M, Thieriault R, Ottesen R, Lepisto E, Weeks JC. (2003) Adoption of sentinel lymph node biopsy as a component of standard care for breast cancer in comprehensive cancer centers. Provisionally accepted. J Natl Cancer Inst. (Jan), 95: 1514-1521.
Christian CK, Edge SB, Niland J, Ottesen R, Hughes M, Wilson J, Hergrueter C, Weeks JC. (2003) A Multi-Institutional Analysis of the Socioeconomic Determinants of Breast Reconstruction. J Surg Res (Jan), 114(2): 294.
Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, Peterson B, Hwang YT, Weeks JC. (2002) Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma. Cancer (Dec), 95(12): 2445-2454.
McKee MD, Cropp MD, Hyland A, Watroba N, McKinley B, Edge SB. (2002) Provider case volume and outcome in the evaluation and treatment of patients with mammogram-detected breast carcinoma. Cancer (Aug), 95(4): 704-712.
Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP. (2002) American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol (Aug), 20(15): 3317-3327.
Edge SB, Gold K, Berg CD, Meropol NJ, Tsangaris TN, Gray L, Petersen BM, Hwang YT, Mandelblatt JS. (2002) Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma. Cancer (May), 94(10): 2534-2541.
Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, Peterson B, Zhong A, Hwang YT, Weeks JC. (2002) Sequelae of Axillary Node Dissection in Older Women with Stage 1 and !! Breast Cancer. Cancer (Jan), 95(12): 2445-2454.
Winer EP, Hudis C, Harold J, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles, Whelan TJ, Browman GP. (2002) American Society of Clinical Oncology Trechnology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women with Hormone Receptor Positive Breast Cancer: Status Report 2002. J Clin Oncol. (Jan), 20: 3317-3327.
Sabel MS, Zhang P, Barnwell JM, Winston JS, Hurd TC, Edge SB. (2001) Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma. J Surg Oncol (Aug), 77(4): 243-246.
Sabel MS, Levine EG, Hurd T, Schwartz GN, Zielinski R, Hohn D, Edge SB. (2001) Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition. Am J Clin Oncol (Aug), 24(4): 425-428.
Kane JM, Edge SB, Winston JS, Watroba N, Hurd TC. (2001) Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann Surg Oncol (May), 8(4): 361-367.
Mandelblatt JS, Berg CD, Meropol NJ, Edge SB, Gold K, Hwang YT, Hadley J. (2001) Measuring and predicting surgeons' practice styles for breast cancer treatment in older women. Med Care (Mar), 39(3): 228-242.
Mandelblatt JS, Berg CD, Meropol NJ, Edge SB, Gold K, Hwang YT, Hadley J. (2001) Measuring and predicting surgeons‘ practice styles for breast cancer treatment in older women. Med Care (Mar), 39(3): 228-242.
Khatri VP, Hurd T, Edge SB. (2001) Simple technique of early identification of the thoracodorsal nerve during axillary dissection. J Surg Oncol (Feb), 76(2): 141-142.
Khatri VP, Hurd TC, Edge SB. (2001) Simple Technique of Early Identification of the Thoracolorsal Nerve During Axillary Dissection. Journal of Surgical Oncology (Jan), 76: 141-142.
Carlson RW, Edge SB, Theriault R. (2001) National Comprehensive Cancer Network 6th Annual Conference Proceedings: Breast Cancer. Cancer Control (Jan), 8(6): 54-59.
Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook S, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge GW, Jr., Whelan TJ. (2001) Postmastectomy Radiotherapy Guidelines of the American Society of Clinical Oncology. Journal of Clinical Oncology (Jan), 19: 1539-1569.
Sabel MS, Zhang P, Barnwell JM, Winston JS, Hurd TC, Edge SB. (2001) Accuracy of Sentinel Node Metastases in Predicting the Nodal Status in Patients with Breast Carcinoma. J Surg Onc (Jan), 77: 243-246.
Masso-Welch PA, Winston JS, Edge S, Darcy KM, Asch H, Vaughan MM, Ip MM. (2001) Altered expression and localization of PKC eta in human breast tumors. Breast Cancer Research and Treatment (Jan), 68: 211-213.
Swede H, Moysich KB, Freudenheim JL, Quirk JT, Muti PC, Hurd TC, Edge SB, Winston JS, Michalek AM. (2001) Breast Cancer Risk Factors and HER-2 Overexpression in Tumors. Cancer (Jan), 25(6): 511-519.
Swede H, Moysich KB, Freudenheim JL, Quirk JT, Muti PC, Hurd TC, Edge SB, Winston JS, Michalek AM. (2001) Breast cancer risk factors and HER2 over-expression in tumors. Cancer Detect Prev (Jan), 25(6): 511-519.
Edge SB, Pisters PWT. (2001) Defining Core Information for the Training and Continuing Education of Surgical Oncologists (editorial). Annals of Surgical Oncology (Jan), 8(7): 562-563.
Winston JS, Asch HL, Zhang PJ, Edge SB, Hyland A, Asch BB. (2001) Downregulation of gelsolin correlates with the progression to breast carcinoma. Breast Cancer Res Treat (Jan), 65(1): 11-21.
Sabel MS, Edge SB. (2001) In-situ ablation of breast cancer. Breast Dis (Jan), 12: 131-140.
Waddell BE, Stomper PC, DeFazio JL, Hurd TC, Edge SB. (2000) Postexcision mammography is indicated after resection of ductal carcinoma-in-situ of the breast. Ann Surg Oncol (Oct), 7(9): 665-668.
Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GN, Ruby SC, O‘Malley F, Sipson FJ, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ. (2000) Prognostic Factors in Breast Cancer: College of American Pathologist Consensus Statement 1999. Archives Pathol Lab Med (Jan), 124: 966-978.
Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffeth J, Edge SB, Guadagnoli E, Lynch JJ, Meropol NJ, Weeks JC, Winn R. (2000) Patterns of Breast Cancer Treatment in Older Women: Patient Preference and Clinical and Physician Influence. Cancer (Jan), 89: 561-573.
Waddell B, Stomper P, Hurd TC, Edge SB. (2000) Post-Excision Mammography is Indicated After Resection of Ductal Carcinoma in Situ. Annals of Surgical Oncology (Jan), 7(9): 665-668.
Carlson RW, Anderson BO, Bensinger W, Cox CE, Davidson NE, Edge SB, Farrar WB, Goldstein LF, Gradishar WJ, Lichter AS, McCormick B, Nabell LM, Reed ED, Silver SM, Smith ML, Somlo G, Theriault R, Ward JH, Winer EP, Wolff A. (2000) NCCN Practice Guidelines for Breast Cancer. Oncology (Jan), 14(11A): 33-49.
Xu Y, Edge S, Hurd T, Repasky E, Slocum HK. (2000) Implantation and Characterization of Human Breast Carcinomas in SCID Mice. Methods in Mammary Gland Biology and Breast Cancer Research. Ip M and Asch M, eic. Kluwer Academic (Jan)51-63.
Box JC, Edge SB. (1999) Laparoscopic cholecystectomy and unsuspected gallbladder carcinoma. Semin Surg Oncol (Jun), 16(4): 327-331.
Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB. (1999) Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion. Breast Cancer Res Treat (May), 55(2): 179-188.
Asch HL, Winston JS, Edge SB, Stomper P, Asch B. (1999) Down-Regulation of Gelsolin Expression in Human Breast Ductal Carcinoma With and Without Invasion. Breast Cancer Research and Treatment (Jan), 55: 179-188.
Yarussi A, Sands R, Edge SB, Lema MJ, DeLeon-Casasola OA. (1999) Evaluation of Peripheral Morphine Analgesia for Lumpectomy and Axillary Node Dissection: A Randomized, Double-Blinded Placebo-Controlled Study. Regional Anesthesia and Pain Medicine (Jan), 24(2): 142-145.
Hurd TC, Edge SB. (1999) Breast cancer imaging. Surg Oncol Clin N Am (Jan), 8(1): 1-15.
Stomper PC, Waddell BE, Edge SB, Klippenstein DL. (1999) Breast MRI in the Evaluation of Patients With Occult Primary Breast Carcinoma. The Breast Journal (Jan), 5(4): 230-234.
Yarussi AT, Sands RP, Edge SB, Lema MJ, deLeon-Casasola OA. (1999) Peripheral Morphine Analgesia for Postoperative Pain Following Axillary Node Dissection for Breast Cancer: A Controlled Randomized Double-Blind Study. Regional Anesthesia (Jan), 24: 142-145.
Edge SB, Hurd TC. (1999) Sentinel Node Update: Breast Cancer. Oncology (Jan), 13(11A): 213-218.
Kollmorgen DR, Varanasi JS, Edge SB, Carson WE. (1998) Paget's disease of the breast: a 33-year experience. J Am Coll Surg (Aug), 187(2): 171-177.
Zhang PJ, Reisner RM, Nangia R, Edge SB, Brooks JJ. (1998) Effectiveness of multiple-level sectioning in detecting axillary nodal micrometastasis in breast cancer: a retrospective study with immunohistochemical analysis. Arch Pathol Lab Med (Aug), 122(8): 687-690.
Barnwell JM, Arredondo MA, Kollmorgen D, Gibbs JF, Lamonica D, Carson W, Zhang P, Winston J, Edge SB. (1998) Sentinel node biopsy in breast cancer. Ann Surg Oncol (Mar), 5(2): 126-130.
North JH, McPhee M, Arredondo M, Edge SB. (1998) Sarcoma of the Breast: Implications of the Extent of Local Therapy. American Surgeon (Jan), 64: 1059-1061.
Kollmorgen DR, Varanasi JS, Edge SB, Carson WE. (1998) Paget's Disease of the Breast: A 33 Year Experience. Journal of the American College of Surgeons (Jan), 187: 171-177.
Zhang PJ, Reisner RM, Nangia R, Edge SB, Brooks JJ. (1998) Effectiveness of Multiple-Level Sectioning in Detecting Axillary Nodal Metastases in Breast Cancer. A Retrospective Study with Immunohistochemical Analysis. Archives of Pathology and Laboratory Medicine (Jan), 122: 687-690.
Beitler AL, Hurd TC, Edge SB. (1997) The evaluation of palpable breast masses: common pitfalls and management guidelines. Surg Oncol (Dec), 6(4): 227-234.
Edge SB. (1997) Breast Cancer Practice Guidelines: Evaluation and Quality Improvement. Oncology (Jan), 11(11a): 151-154.
Sakakibara T, Xu Y, Bumpers HL, Chen FA, Bankert RB, Arredondo MA, Edge SB, Repasky EA. (1996) Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice. Cancer J Sci Am (Sep), 2(5): 291-300.
Cuenca RE, Giachino J, Arredondo MA, Hempling R, Edge SB. (1996) Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use. Cancer (May), 77(10): 2058-2063.
Sakakibara T, Xu Y, Bumpers HL, Chen FA, Bankert RB, Arredondo MA, Edge SB, Repasky EA. (1996) Growth and Metastasis of Surgical Speciments of Human Breast Carcinomas in SCID Mice. the Cancer Journal from Scientific American (Jan), 2: 291-300.
Cuenca RE, Giachina J, Arredondo AM, Hempling R, Edge SB. (1996) Endometrial Cancer Associated with Breast Cancer: Low Incidence with Tamoxifen Use. Cancer (Jan), 77: 2058-2063.
McPhee M, Edge SB, Loree T. (1996) Breast Cancer After Breast Augmentation. Current Problems in General Surgery (Jan), 13(1): 101-109.
Stomper PC, Penetrante RB, Edge SB, Arredondo MA, Blumenson LE, Stewart CC. (1996) Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage. Breast Cancer Res Treat (Jan), 37(3): 229-236.
Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE. (1996) Suspect Breast Lesions: Findings at Dynamic Gadolinium-Enhanced MR Imaging Correlated With Mammographic and Pathologic Features. Radiology (Jan), 197: 387-395.
Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE. (1995) Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology (Nov), 197(2): 387-395.
Green DM, Edge SB, Penetrante RB, Bakshi S, Shedd D, Zevon MA. (1995) In situ breast carcinoma after treatment during adolescence for thyroid cancer with radioiodine. Med Pediatr Oncol (Feb), 24(2): 82-86.
Bauer RL, Busch E, Levine E, Edge SB. (1995) Therapy of Inflammatory Breast Cancer; Impact of Doxorubicin-based Therapy. Annals of Surgical Oncology (Jan), 2(4): 228-294.
Carson W, Sanchez-Forgach E, Stomper P, Penetrante R, Tsangaris TN, Edge SB. (1994) Lobular carcinoma in situ: observation without surgery as an appropriate therapy. Ann Surg Oncol (Mar), 1(2): 141-146.
Carson W, Sanchez-Forgach E, Stomper P, Penetrante R, Edge SB. (1994) Management of Lobular Carcinoma In Ssitu: Observation Without Surgery as an Appropriate Therapy. Annals of Surgical Oncology (Jan), 1(2): 141-146.
Edge SB, Schmieg RE, Rosenlof LK, Wilhelm MC. (1993) Pancreas cancer resection outcome in American University centers in 1989-1990. Cancer (Jun), 71(11): 3502-3508.
Edge SB, Schmieg RE, Rosenlof LK, Wilhelm MC. (1993) Pancreas Cancer Resections in American University Center: Outcome for 223 Resections in 1989-1990. Cancer (Jan), 71: 3502-3508.
Schirmer BD, Schmeig RE Jr., Dix J, Edge SB, Hanks JB. (1993) Laparoscopic Versus Traditional Appendectomy for Suspected Appendicitis. American Journal of Surgery (Jan), 165: 670-675.
de Lange EE, Fechner RE, Spaulding CA, Edge SB. (1992) Rectal carcinoma treated by preoperative irradiation: MR imaging and histopathologic correlation. AJR Am J Roentgenol (Feb), 158(2): 287-292.
DeLange EE, Fechner RE, Spaulding CA, Edge SB. (1992) MrI Evaluation of Rectal Cancer Response to Preoperative Radiation Therapy. American Journal of Radiology (Jan), 158: 287-292.
Schirmer BD, Dix J, Edge SB, Hyser MJ, Hank JM, Aguilar M. (1992) Laparoscopic Cholecystectomy in the Obese Patient. Annals of Surgery (Jan), 216(2): 146-152.
McKinney CD, Frierson HF, Fechner RE, Wilhelm MC, Edge SB. (1992) Pathologic findings in Nonpalpable Invasive Breast Cancer. American Journal of Surgical Pathology (Jan), 16: 33-36.
Schirmer BC, Edge SB, Dix J, Miller A. (1992) Incorporation of Laparoscopy Into a Residency Training Program. American Journal of Surgery (Jan), 163: 46-52.
Schirmer BD, Edge SB, Dix J, Miller AD. (1992) Incorporation of laparoscopy into a surgical endoscopy training program. Am J Surg (Jan), 163(1): 46-50.
Spaulding CA, DeParades ES, Anne P, Edge SB, Wilhelm MC. (1992) Detection of Recurrence After Breast Conservation Treatment with Radiotherapy. Breast Disease (Jan), 158: 287-292.
Wilhelm MC, Edge SB, Cole DD, deParedes E, Frierson HF. (1991) Nonpalpable invasive breast cancer. Ann Surg (Jun), 213(6): 600-603.
Schirmer BD, Edge SB, Dix J, Hyser MJ, Hanks JB, Jones RS. (1991) Laparoscopic cholecystectomy. Treatment of choice for symptomatic cholelithiasis. Ann Surg (Jun), 213(6): 665-676.
Schirmer BD, Edge SB, Dix J, Hyser MJ, Hanks JB, Jones RS. (1991) Laparoscopic Cholecystectomy is the Treatment of Choice for Symptomatic Cholelithiasis. Annals of Surgery (Jan), 213: 665-677.
Wilhelm MC, Edge SB, Cole DD, DeParades E, Frierson HR Jr. (1991) Non-Palpable Invasive Breast Cancer. Annals of Surgery (Jan), 213: 600-605.
de Lange EE, Fechner RE, Edge SB, Spaulding CA. (1990) Preoperative staging of rectal carcinoma with MR imaging: surgical and histopathologic correlation. Radiology (Sep), 176(3): 623-628.
DeLange EE, Fechner RE, Edge SB, Spaulding CA. (1990) Preoperative Staging of Rectal Cancer with MR Imaging: Surgical and Histopathologic Correlation. Radiology (Jan), 176: 623-628.
Edge SB, Schirmer BD, Dix J. (1990) New for gallstones: video laparoscopy for cholecystectomy. Va Med Q (Jan), 117(8): 366-367.
Edge SB, Schirmer BD, Dix J. (1990) A New Technique for Gallstones: Laparoscopic Cholecystectomy at UVA. Virginia Medical Quarterly (Jan), 117: 336-339.
Edge SB, Funkhouser WK, Berman A, Seipp C, Tanner A, Wesley R, Rosenberg SA, Chang AE. (1987) High-dose oral and intravenous metoclopramide in doxorubicin/cyclophosphamide-induced emesis. A randomized double-blind study. Am J Clin Oncol (Jun), 10(3): 257-263.
Edge SB, Funkhouser WK, Berman A, Seipp C, Tanner A, Wesley R, Rosenberg SA, Chang AE. (1987) High Dose Oral and Intravenous Metoclopramide in Doxorubicin/Cyclophosphamide Induced Emesis: A Randomized Double Blind Study. American Journal of Clinical Oncology (Jan), 10: 257-263.
Hoeg JM, Edge SB, Demosky SJ, Starzl TE, Triche T, Gregg RE, Brewer HB. (1986) Metabolism of low-density lipoproteins by cultured hepatocytes from normal and homozygous familial hypercholesterolemic subjects. Biochim Biophys Acta (May), 876(3): 646-657.
Edge SB, Hoeg JM, Triche T, Schneider PD, Brewer HB. (1986) Cultured human hepatocytes. Evidence for metabolism of low density lipoproteins by a pathway independent of the classical low density lipoprotein receptor. J Biol Chem (Mar), 261(8): 3800-3806.
Edge SB, Hoeg JM, Triche T, Schneider PD, Brewer HB, Jr. (1986) Cultured Human Hepatocytes: Evidence for Metabolism of Low Density Lipoproteins by a Pathway Independent of the Classical Low Density Lipoprotein Receptor. Journal of Biological Chemistry (Jan), 261: 3800-3806.
Edge SB, Hoeg JM, Schneider PD, Brewer HB Jr. (1985) Apolipoprotein B Synthesis in Humans: Liver Synthesizes Only Apolipoprotein B-100. Metabolism (Jan), 34: 726-730.
Hoeg JM, Demosky SJ, Jr., Edge SB, Gregg RE, Osborne JC, Brewer HB, Jr. (1985) Characterization of a Human Hepatic Receptor for High Density Lipoproteins. Arteriosclerosis (Jan), 5: 228-237.
Hoeg JM, Edge SB, Demosky SJ, Jr., Starzl TE, Triche T, Gregg RE, Brewer HB, Jr. (1985) Metabolism of Low Density Lipoproteins by Cultured Hepatocytes from Normal and Homozygous Familial Hypercholesterolemic Subjects. Biochem Biophys Acta (Jan), 876: 646-657.
Lackner KJ, Edge SB, Gregg RE, Hoeg JM, Brewer HB, Jr. (1985) Isoforms of Apolipoprotein A-11 In Human Plasma and Thoracic Duct Lymph: Identification of Proapolipoprotein A-11 and Sialic Acid-Containing Isoforms. Journal of Biological Chemistry (Jan), 260: 703-706.
Lackner KJ, Edge SB, Gregg RE, Hoeg JM, Brewer HB. (1985) Isoforms of apolipoprotein A-II in human plasma and thoracic duct lymph. Identification of proapolipoprotein A-II and sialic acid-containing isoforms. J Biol Chem (Jan), 260(2): 703-706.
Edge SB, Gorschboth C, Schneider PD. (1982) Selective Inhibition of Tumor Cell Growth by Sterol Synthesis Inhibition. Surgical Forum (Jan), 33: 398-400.
Swede H, Moysich KB, Freudenheim JL, Quirk JT, Muti PC, Hurd TC, Edge SB, Winston JS, Michalek AM. (1900) Breast cancer risk factors and HER2 over-expression in tumors. Cancer Detect Prev (Jan), 25(6): 511-519.

See all (328 more)

Books and Book Chapters:

Xu Y, Edge SB, Hurd TC, Repasky E, Slocum HK. (1900) Implantation and characterization of human breast carcinomas in SCID mice.

Abstracts:

Wilkinson NW, Shahryarinejad A, Winston JS, Watroba N, Edge SB. (2003) Concordance with breast cancer pathology reporting practice guidelines: Community-wide practice. Journal of the American College of Surgeons (in press – accepted August, 2002, Elsevier Science Journals Reference Number ACS2106 - anticipated publication December, 2002), (Jan) 38-43
McKee M, Cropp M, Hyland A, Watroba N, McKinely B, Edge SB. (2002) Provider case volume and outcome in the evaluation and treatment of mammogram-detected breast cancer. Cancer 2002, (Jan) 704-712
Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RVP, Morrow M, Page DL, Recht A, Theriault RL,Thor A, Weaver DL, Wieand HS, Greene FL. (2002) Revision of the American Joint Committee on Cancer Staging System for Breast Cancer. J Clin Oncol 2002, (Jan) 3628-3636
Proulx GM, Loree T, Edge S, Hurd T, Stomper P. (2002) Outcome with post mastectomy radiation with TRAM flap breast reconstruction. American Surgeon 2002, (Jan) 410-413
Edge SB, Gold K, Berg CD, Meropol NJ, Tsangaris TN, Gray L, Petersen BM, Hwang YT, Mandelblatt JS. (2002) Patient and provider characteristics affecting use of axillary dissection in older women with Stage I/II breast cancer. Cancer 2002, (Jan) 2534-2541
Proulx GM, Hurd T, Lee RJ, Stomper PC, Podgorsak MB, Edge SB. (2001) Intraoperative radiation therapy (IORT) to the tumor bed only for breast cancer: technique and outcome. Radiation Oncology 2001, (Jan) 35-41
Edge SB, Fritz A, Clutter GG, Page DL, Watkins S, Blankenship C, Douglas K, Fleming I. (1999) A unified cancer stage data collection system: Preliminary report from the Collaborative Stage Task Force / American Joint Committee on Cancer. Journal of Registry Management 1999, (Jan) 57-61
Yates J, Edge SB. (1999) Evaluating guidelines: an important step in improving cancer care. Oncology (Huntingt) 1999, (Jan) 523-528
Yarussi A, Sands R, Edge SB, Lema MJ, deLeon-Casasola OA. (1900) Evaluation of peripheral morphine analgesia for lumpectomy and axillary node dissection: A randomized, double-blinded placebo-controlled study. Regional Anesthesia and Pain Medicine. 1999, (Jan) 142-145
Edge SB. (1900) Evidence-based breast cancer staging (editorial). Breast Diseases: A Year Book Quarterly 2001, (Jan) 257-258
Winer EP, Hudis C, Harold J. Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles, Whelan TJ, Browman GP. (1900) American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women with Hormone Receptor Positive Breast Cancer: Status Report 2002. J Clin Oncol. 2002, (Jan) 3317-3327
Carlson RW, Anderson BO, Bensinger W, Cox C. Davidson NE, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Lichter AS, McCormick B, Nabell LM, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Winer EP. (1900) National Cancer Center Network Breast Cancer Guidelines. Oncology (Huntington) 1999, (Jan) 41-66
Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffeth J, Edge S, Guadagnoli E, Lynch JJ, Meropol NJ, Weeks JC, Winn R. (1900) Patterns of breast cancer treatment in older women - Patient preference and clinical and physician influence. Cancer 2000, (Jan) 561-573
Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, Peterson B, Zhong A, Hwang YT, Weeks JC. (1900) Sequelae of axillary node dissection in older women with localized breast cancer. Cancer (in press – accepted June, 2002 – Manuscript #C-0628-02), (Jan)
Swede H, Moysich KB, Winston JS, Hurd TC, Edge SB, Gutierriz-Romero M, Brooks JSJ, Michalek AM. (1900) Variation of prognostic significance of HER2 expression in breast cancer according to tumor size. The Breast Journal (in press – Manuscript #21124), (Jan)

See all (5 more)

Presentations:

"3. Hemorrhage Without Tissue Trauma Produces Immunosuppression." Annual Meeting of the Society of University Surgeons,; ; (Residenß' Meeting). (1986)
"Parenchymal and Non-Parenchymal Liver Cell Response to Regenerating Liver Cytosol." American College of Surgeons (1985)
"In Vitro Liver Regeneration." Grand Rounds; ; Yale University School of Medicine (1984)

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

scroll-out

Contact Information

Roswell Park Cancer Institute
Elm & Carlton Streets
Department of Surgery
Buffalo, New York 14263
edge@buffalo.edu

View map

Jacobs School of Medicine
and Biomedical Sciences

Stephen B. Edge MD, FACS, FASCO

Stephen B. Edge
MD, FACS, FASCO

Specialty/Research Focus

Professional Summary:

Education and Training:

Employment:

Journal Articles:

Books and Book Chapters:

Abstracts:

Presentations:

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

Jacobs School of Medicine and Biomedical Sciences

Join the School

Get Involved

Find People

UB Academic Health Center

Connect with Us

About The School

Centers and Affiliations

Education and Training

Research Facilities and Services

Health Care

Resources by Audience

Alumni and Friends

Governance

Learning Resources

Support Services

Site Tools

Jacobs School of Medicine and Biomedical Sciences

Jacobs School of Medicineand Biomedical Sciences

Stephen B. Edge MD, FACS, FASCO

Stephen B. Edge MD, FACS, FASCO

Specialty/Research Focus

Professional Summary:

Education and Training:

Employment:

Journal Articles:

Books and Book Chapters:

Abstracts:

Presentations:

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

Jacobs School of Medicine and Biomedical Sciences

Join the School

Get Involved

Find People

UB Academic Health Center

Connect with Us

About The School

Centers and Affiliations

Education and Training

Research Facilities and Services

Health Care

Resources by Audience

Alumni and Friends

Governance

Learning Resources

Support Services

Site Tools

Jacobs School of Medicine and Biomedical Sciences

Jacobs School of Medicine
and Biomedical Sciences

Stephen B. Edge
MD, FACS, FASCO